“The general consensus is that [the car park] is a huge waste of money,” says Sarah*, the owner of a shop in Eynsham. “[The money required to maintain it for three years] is a complete ...
Accession Therapeutics, which is developing novel immunotherapies targeted at tumour sites and administered systemically, has filed a clinical trial application (CTA) with regulatory agency MHRA. This ...